Cost-effectiveness intervention thresholds for romosozumab and teriparatide in the treatment of osteoporosis in the UK
Journal article
Borgström, Fredrik, Lorentzon, Mattias, Johansson, Helena, Harvey, Nicholas C., McCloskey, Eugene, Willems, Damon, Knutsson, Douglas and Kanis, John A.. (2024). Cost-effectiveness intervention thresholds for romosozumab and teriparatide in the treatment of osteoporosis in the UK. Osteoporosis International. 35(12), pp. 2183-2193. https://doi.org/10.1007/s00198-024-07251-w
Authors | Borgström, Fredrik, Lorentzon, Mattias, Johansson, Helena, Harvey, Nicholas C., McCloskey, Eugene, Willems, Damon, Knutsson, Douglas and Kanis, John A. |
---|---|
Abstract | Summary Purpose Methods Results Conclusion |
Keywords | cost-effectiveness; economic evaluation; FRAX; intervention thresholds; Markov microsimulation model; osteoporosis; recent fracture |
Year | 2024 |
Journal | Osteoporosis International |
Journal citation | 35 (12), pp. 2183-2193 |
Publisher | Springer |
ISSN | 1433-2965 |
Digital Object Identifier (DOI) | https://doi.org/10.1007/s00198-024-07251-w |
PubMed ID | 39365433 |
Scopus EID | 2-s2.0-85205565125 |
Page range | 2183-2193 |
Funder | Osteoporosis Research Ltd |
UCB Pharma | |
Amgen, Inc. | |
Publisher's version | License All rights reserved File Access Level Controlled |
Output status | Published |
Publication dates | |
Online | 04 Oct 2024 |
Publication process dates | |
Accepted | 08 Sep 2024 |
Deposited | 05 Jun 2025 |
Additional information | © International Osteoporosis Foundation and Bone Health and Osteoporosis Foundation 2024. |
https://acuresearchbank.acu.edu.au/item/91yq3/cost-effectiveness-intervention-thresholds-for-romosozumab-and-teriparatide-in-the-treatment-of-osteoporosis-in-the-uk
Restricted files
Publisher's version
2
total views0
total downloads2
views this month0
downloads this month